Michael Barbella, Managing Editor10.29.22
Change was in the air this past week, both literally and figuratively.
The former manifested itself in falling (or rising) temperatures, while the latter materialized via MPO's website traffic.
The top pageview generator over the past seven days was Heraeus Medical Components's name change after almost 20 years in the medical device industry. Its new name—Heraeus Medevio—reflects the company’s expanding offerings in design, development, and commercialization for its partners in the medical device industry while maintaining its expertise in assemblies, components, and supply chain optimization. The name was selected through an intentional process involving employees, leadership, and customer feedback, and is comprised of three elements; “med,” representing the company’s foundation in medical components, “dev,” for the current expanded expertise in design and development, and “vio,” reflecting the path the company is on to reach its vision of improving 100 million lives each year.
Change is coming to Medtronic as well. The worlds largest medical device manufacturer is spinning off its combined Patient Monitoring and Respiratory Interventions businesses to "focus on opportunities better aligned" with the firm's long-term strategies. Following the separation of the businesses, Medtronic will have a more streamlined portfolio with sharpened focus on deploying capital into opportunities most aligned with its long-term growth strategies; modestly faster organic revenue growth and an increased weighted average market growth rate; and a strong balance sheet and continued commitment to its strategy of driving durable growth. The separation is expected to be completed in the next 12 to 18 months.
Medtronic also unveiled a a new program for individuals using its MiniMed 770G system. Using an individual's data, the "My Insights" program relies on the power of data science to provide personalized tips, trends, and reminders that customers can use to help with their diabetes management goals. My Insights' personalized recommendations are shared via a monthly email with educational content that is most relevant based on what an individual may currently be experiencing.
Change also may be coming to medtech manufacturers planning to invest in China, as the country's efforts to strengthen its medical devices industry may create a trust deficit and discourage multinatiional financing.
The former manifested itself in falling (or rising) temperatures, while the latter materialized via MPO's website traffic.
The top pageview generator over the past seven days was Heraeus Medical Components's name change after almost 20 years in the medical device industry. Its new name—Heraeus Medevio—reflects the company’s expanding offerings in design, development, and commercialization for its partners in the medical device industry while maintaining its expertise in assemblies, components, and supply chain optimization. The name was selected through an intentional process involving employees, leadership, and customer feedback, and is comprised of three elements; “med,” representing the company’s foundation in medical components, “dev,” for the current expanded expertise in design and development, and “vio,” reflecting the path the company is on to reach its vision of improving 100 million lives each year.
Change is coming to Medtronic as well. The worlds largest medical device manufacturer is spinning off its combined Patient Monitoring and Respiratory Interventions businesses to "focus on opportunities better aligned" with the firm's long-term strategies. Following the separation of the businesses, Medtronic will have a more streamlined portfolio with sharpened focus on deploying capital into opportunities most aligned with its long-term growth strategies; modestly faster organic revenue growth and an increased weighted average market growth rate; and a strong balance sheet and continued commitment to its strategy of driving durable growth. The separation is expected to be completed in the next 12 to 18 months.
Medtronic also unveiled a a new program for individuals using its MiniMed 770G system. Using an individual's data, the "My Insights" program relies on the power of data science to provide personalized tips, trends, and reminders that customers can use to help with their diabetes management goals. My Insights' personalized recommendations are shared via a monthly email with educational content that is most relevant based on what an individual may currently be experiencing.
Change also may be coming to medtech manufacturers planning to invest in China, as the country's efforts to strengthen its medical devices industry may create a trust deficit and discourage multinatiional financing.